Novel atopic dermatitis-associated gene and proteins
CA 2432715 A1 · Owner: Mochida Pharmaceutical Co. Ltd. · Inventors: Nagase, Takahiro; Negishi, Takaaki; Mizushima, Seiichi
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A gene and/or a protein relating to the prevention or treatment of atopic diseases and dermatitis, in particular atopic dermatitis are provided. An EST fragment comprising the base sequence of SEQ ID NO:1; a DNA comprising the base sequence represented by SEQ ID NO:2; a DNA hybridizable with the DNA of SEQ ID NO:2 under stringent conditions and encoding a protein having an activity of binding to DNA; and a protein encoded by the above DNA. An antisense nucleic acid to the DNA sequence as described above; a method of searching for a substance capable of controlling the expression of the above DNA or the activity of the protein; and a test reagent and a test method for allergic …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 21, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 21, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 21, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.